Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | PK9C5 | IM / LA |
patient is G2P0101 that is 33 weeks and 4 days gestation when she presented to the PCP office with a letter from her OB/GYN provider requesting for patient to receive the RSV vaccine, her first baby was born at 32 weeks by C-section due to a complete placenta abruption, patient's due date for this current pregnancy is 11-22-25.
ASA 81mg and PNV
Amoxicillin
N/A